106 results on '"Redfield, M. M."'
Search Results
2. Cyclic gmp enhancing therapy promotes titin phosphorylation and corrects high cardiomyocyte passive stiffness in heart failure with preserved ejection fraction: 514
3. Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study
4. Activation of cardiorenal and pulmonary tissue endothelin-1 in experimental heart failure
5. Contemporary Trends in Heart Failure With Reduced and Preserved Ejection Fraction After Myocardial Infarction: A Community Study
6. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction
7. Renal function and mortality following cardiac resynchronization therapy
8. Progression of preclinical diastolic dysfunction to the development of symptoms
9. Right ventricular function in patients with preserved and reduced ejection fraction heart failure
10. Exploratory study of relationship between hospitalized heart failure patients and chronic renal replacement therapy
11. Modern Management of Chronic Heart Failure: From Stage a to Stage D and beyond
12. Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures
13. Ventricular remodeling during development and recovery from modified tachycardia-induced cardiomyopathy model
14. Analysis of left ventricular diastolic function
15. Cardiac secretion of adrenomedullin in human heart failure.
16. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
17. Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure
18. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction.
19. Cardiac atrial natriuretic factor during evolution of congestive heart failure
20. Load versus humoral activation in the genesis of early hypertensive heart disease.
21. Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing-induced heart failure in the dog.
22. Mechanical unloading versus neurohumoral stimulation on myocardial structure and endocrine function In vivo.
23. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
24. Regulation of cardiac adrenomedullin in heart failure
25. Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure
26. Doppler Evaluation of Patients With Constrictive Pericarditis: Use of Tricuspid Regurgitation Velocity Curves to Determine Enhanced Ventricular Interaction
27. Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
28. Nesiritide in acute decompensated heart failure: Current status and future perspectives
29. Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog.
30. Restoration of renal response to atrial natriuretic factor in experimental low-output heart failure
31. Integrated cardiac, renal, and endocrine actions of endothelin.
32. Assessment of Mean Left Atrial Pressure from the Left Ventricular Tracing in Patients With Cardiomyopathies
33. Diastolic dysfunction was predictive of all cause mortality.
34. Natural History of Incidentally Discovered, Asymptomatic Idiopathic Dilated Cardiomyopathy
35. Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
36. Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice.
37. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.
38. Heart failure with preserved systolic function. A different natural history?
39. Approach to patients with heart failure and normal ejection fraction.
40. Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
41. Diastolic dysfunction: insights into pathophysiology and pharmacotherapy.
42. Radiographic measurements of cardiac size as predictors of outcome in patients with dilated cardiomyopathy.
43. Subcutaneous administration of brain natriuretic peptide in experimental heart failure.
44. The role of coenzyme Q10 in the pathophysiology and therapy of experimental congestive heart failure in the dog.
45. Diastolic heart failure in the community.
46. Effects of adrenomedullin on load and myocardial performance in normal and heart-failure dogs.
47. Clinical criteria and biochemical markers for the detection of systolic dysfunction.
48. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation.
49. Failing energetics in failing hearts.
50. Epidemiology and pathophysiology of heart failure.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.